Open-label Extension to the Phase 2 Crossover Study (PRESIDIO) Evaluating KZR-616 in Patients With PM and DM.
Clinical trial NCT04628936 · COMPLETED
Trial details
- NCT number
- NCT04628936
- Sponsor
- Kezar Life Sciences, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-04
- Primary completion
- 2023-03-10
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.